Total submissions: 5
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV001388258 | SCV001589178 | pathogenic | Leber congenital amaurosis 2; Retinitis pigmentosa 20 | 2023-11-27 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Thr147Argfs*9) in the RPE65 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in RPE65 are known to be pathogenic (PMID: 9326941, 9501220, 9843205, 18632300). This variant is present in population databases (no rsID available, gnomAD 0.0009%). This premature translational stop signal has been observed in individual(s) with clinical features of Leber congenital amaurosis (PMID: 17724218). This variant is also known as c.438-439delCA. ClinVar contains an entry for this variant (Variation ID: 973965). Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. |
Fulgent Genetics, |
RCV002499440 | SCV002813839 | pathogenic | Leber congenital amaurosis 2; Retinitis pigmentosa 20; Retinitis pigmentosa 87 with choroidal involvement | 2024-04-30 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV001250704 | SCV005055434 | pathogenic | Leber congenital amaurosis 2 | 2024-03-18 | criteria provided, single submitter | clinical testing | |
Laboratory of Genetics in Ophthalmology, |
RCV001250704 | SCV001425579 | pathogenic | Leber congenital amaurosis 2 | no assertion criteria provided | research | ||
Natera, |
RCV001830054 | SCV002092770 | pathogenic | Leber congenital amaurosis | 2020-09-14 | no assertion criteria provided | clinical testing |